Leukopenia News and Research

RSS
Leukopenia is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection.
ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

CHMP recommends approval of Xofigo for CRPC, symptomatic bone and visceral metastases

CHMP recommends approval of Xofigo for CRPC, symptomatic bone and visceral metastases

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

New study evaluates effectiveness of radioimmunotherapy in lymphoma patients

New study evaluates effectiveness of radioimmunotherapy in lymphoma patients

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage breast cancer

European Commission amends marketing authorisation for Celgene's REVLIMID

European Commission amends marketing authorisation for Celgene's REVLIMID

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Prostate cancer drug Xofigo gets FDA approval

Prostate cancer drug Xofigo gets FDA approval

Sanofi, Regeneron enroll patients in two sarilumab Phase 3 trials for treatment of RA

Sanofi, Regeneron enroll patients in two sarilumab Phase 3 trials for treatment of RA

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

Boehringer Ingelheim initiates enrollment in Phase III IFN-free HCV trial

Boehringer Ingelheim initiates enrollment in Phase III IFN-free HCV trial